These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 9488075)

  • 1. Retroperitoneal lymphadenectomy for post-chemotherapy residual masses: is a modified dissection and resection of residual masses sufficient?
    Rabbani F; Goldenberg SL; Gleave ME; Paterson RF; Murray N; Sullivan LD
    Br J Urol; 1998 Feb; 81(2):295-300. PubMed ID: 9488075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postchemotherapy retroperitoneal lymph node dissection in advanced testicular cancer: radical or modified template resection.
    Heidenreich A; Pfister D; Witthuhn R; Thüer D; Albers P
    Eur Urol; 2009 Jan; 55(1):217-24. PubMed ID: 18926622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resection of postchemotherapy residual masses and limited retroperitoneal lymphadenectomy in patients with metastatic testicular nonseminomatous germ cell tumors.
    Aprikian AG; Herr HW; Bajorin DF; Bosl GJ
    Cancer; 1994 Aug; 74(4):1329-34. PubMed ID: 8055456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-chemotherapy nerve-sparing laparoscopic retroperitoneal lymph node dissection in stage IIB testicular cancer.
    Kimura Y; Nakamura T; Kawauchi A; Kawabata G; Hongo F; Miki T
    Int J Urol; 2013 Aug; 20(8):837-41. PubMed ID: 23305547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does necrosis on frozen-section analysis of a mass after chemotherapy justify a limited retroperitoneal resection in patients with advanced testis cancer?
    Herr HW
    Br J Urol; 1997 Oct; 80(4):653-7. PubMed ID: 9352708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retroperitoneal lymph node dissection after chemotherapy for germ cell tumours: is a full bilateral template always necessary?
    Steiner H; Peschel R; Bartsch G
    BJU Int; 2008 Aug; 102(3):310-4. PubMed ID: 18325053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modified retroperitoneal lymph node dissection for post-chemotherapy residual tumour: a long-term update.
    Cho JS; Kaimakliotis HZ; Cary C; Masterson TA; Beck S; Foster R
    BJU Int; 2017 Jul; 120(1):104-108. PubMed ID: 28296054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retroperitoneal lymph node dissection as adjuvant therapy in the treatment of non-seminomatous testicular cancer.
    Thijssens K; Vaneerdeweg W; Schrijvers D; Eyskens E; Van Oosterom A
    Acta Chir Belg; 2003; 103(6):599-602. PubMed ID: 14743567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcomes and histological findings of patients with advanced metastatic germ cell tumors undergoing post-chemotherapy resection of retroperitoneal lymph nodes and residual extraretroperitoneal masses.
    Nakamura T; Oishi M; Ueda T; Fujihara A; Nakanishi H; Kamoi K; Naya Y; Hongo F; Okihara K; Miki T
    Int J Urol; 2015 Jul; 22(7):663-8. PubMed ID: 25847721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term oncological outcome after post-chemotherapy retroperitoneal lymph node dissection in men with metastatic nonseminomatous germ cell tumour.
    Fléchon A; Tavernier E; Boyle H; Meeus P; Rivoire M; Droz JP
    BJU Int; 2010 Sep; 106(6):779-85. PubMed ID: 20089110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retroperitoneal lymph node dissection after chemotherapy.
    Winter C; Raman JD; Sheinfeld J; Albers P
    BJU Int; 2009 Nov; 104(9 Pt B):1404-12. PubMed ID: 19840021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of nodal metastases after chemotherapy in nonseminomatous testis cancer: a possible indication for limited dissection.
    Ehrlich Y; Yossepowitch O; Kedar D; Baniel J
    BJU Int; 2006 Jun; 97(6):1221-4. PubMed ID: 16686715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of metastatic nonseminomatous germ cell tumor outside the boundaries of a modified postchemotherapy retroperitoneal lymph node dissection.
    Carver BS; Shayegan B; Eggener S; Stasi J; Motzer RJ; Bosl GJ; Sheinfeld J
    J Clin Oncol; 2007 Oct; 25(28):4365-9. PubMed ID: 17906201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic supine robotic retroperitoneal lymph node dissection for post-chemotherapy residual masses in testicular cancer: technique and outcome analysis of initial experience.
    Tamhankar AS; Patil SR; Ojha SP; Ahluwalia P; Gautam G
    J Robot Surg; 2019 Dec; 13(6):747-756. PubMed ID: 30656537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical outcome of postchemotherapy retroperitoneal lymph node dissection and predicting retroperitoneal histology in advanced nonseminomatous germ cell tumours of the testis].
    Li XD; Guo SJ; Chen SL; Liu ZF; Dong P; Zhang ZL; Jiang LJ; Yao K; Li YH; Han H; Qin ZK; Liu ZW; Zhou FJ
    Zhonghua Wai Ke Za Zhi; 2017 Aug; 55(8):603-607. PubMed ID: 28789511
    [No Abstract]   [Full Text] [Related]  

  • 16. Outcomes after resection of postchemotherapy residual neck mass in patients with germ cell tumors--an update.
    Gupta A; Feifer AH; Gotto GT; Kraus D; Motzer R; Bosl GJ; Bajorin D; Feldman DR; Carver B; Sheinfeld J
    Urology; 2011 Mar; 77(3):655-9. PubMed ID: 21377010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two cycles of cisplatin-based chemotherapy for low-volume retroperitoneal stage II nonseminomatous germ cell tumours.
    Steiner H; Müller T; Gozzi C; Akkad T; Bartsch G; Berger AP
    BJU Int; 2006 Aug; 98(2):349-52. PubMed ID: 16626306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limited post-chemotherapy retroperitoneal resection of residual tumour in non-seminomatous testicular cancer: complications, outcome and quality of life.
    Schmidt AH; Høyer M; Jensen BFS; Agerbaek M
    Acta Oncol; 2018 Aug; 57(8):1084-1093. PubMed ID: 29537330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-chemotherapy retroperitoneal lymph node dissection in the management of metastatic testis cancer: the 16-year experience in an Irish setting.
    Considine S; Heaney R; Conroy R; Thornhill JA
    Ir J Med Sci; 2016 Nov; 185(4):901-907. PubMed ID: 26692387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of histological results from the resection of residual masses at different sites after chemotherapy for metastatic non-seminomatous germ cell tumours.
    Hartmann JT; Candelaria M; Kuczyk MA; Schmoll HJ; Bokemeyer C
    Eur J Cancer; 1997 May; 33(6):843-7. PubMed ID: 9291803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.